Kardigan

NEWS

Vector design of a human heart with flat color and multiple colors line heart shapes. Square composition.

Series A

MyoKardia Alumni Launch Kardigan with $300M to Tackle Heart Disease

After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are back together with a mission to make cardiovascular disease curable and preventable.

January 10, 2025

2 min read

Heather McKenzie

JOBS

IN THE PRESS

Press Releases

Kardigan Raises $254 Million Series B to Advance Late-Stage Portfolio of Personalized Cardiovascular Medicines

October 15, 2025

2 min read

Press Releases

Kardigan Announces Presentation of Positive Phase 2a Data for Danicamtiv in Patients with Dilated Cardiomyopathy at HFSA Annual Scientific Meeting 2025

September 30, 2025

5 min read

Press Releases

Kardigan Advances Late-Stage Portfolio of Personalized Cardiovascular Medicines in Dilated Cardiomyopathy, Acute Severe Hypertension and Calcific Aortic Valve Stenosis

September 25, 2025

6 min read

Press Releases

Kardigan Launches with Industry-Leading Team to Modernize Cardiovascular Drug Development with Late-Stage Portfolio of Personalized Medicines

January 10, 2025

4 min read